Building the Science of Evidence-Informed Prevention Policy: A Multi-level Model for Supporting Substance Misuse Prevention
建立循证预防政策的科学:支持药物滥用预防的多层次模型
基本信息
- 批准号:10660188
- 负责人:
- 金额:$ 76.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAwarenessBehaviorCodeCollaborationsCommunitiesComplementDataFamilyFosteringFrequenciesIncentivesInterventionInterviewLanguageLobbyingMapsModelingMorbidity - disease ratePerceptionPoliciesPolicy MakerPolicy MakingPopulationPreventionPrevention ResearchPrevention programProcessProductivityProtocols documentationPublic HealthPublishingRandomized, Controlled TrialsResearchResearch PersonnelSchoolsScienceSourceStatutes and LawsSurveysTestingTimeTranslatingVotingWorkYoutheffectiveness evaluationeffectiveness researchevidence baseexperimental studyimprovedinsightmodel designmortalitymultilevel analysisoutreachprevention serviceresponsesubstance misusesubstance misuse preventiontheoriestime use
项目摘要
Project Summary
If science is to inform policy and ultimately improve public health, the field needs an effective strategy for directly
supporting policymakers’ use of research evidence. However, our field lacks an evidence-based model designed
for supporting state policymakers’ use of prevention research in crafting legislation. Instead, we continue to
largely rely on ad hoc strategies for translating prevention research (e.g., opportunistic outreach and responding
to policymakers’ requests if or when they are made). Accordingly, we propose an experimental study of a formal,
theory-based approach for supporting policymakers’ use of scientific evidence that does not involve lobbying—
the Research-to-Policy Collaboration (RPC) Model. The RPC fosters productive engagement between the policy
and research communities by implementing systematic capacity building and outreach strategies. Previous
experimental work on the RPC demonstrated the ability of this model to increase engagement between
researchers and policymakers, increase policymakers’ value for research evidence, and improve their use of
scientific evidence in their policymaking.1 We propose a state-level randomized controlled trial of the RPC (N =
30 state legislatures) that will evaluate the model’s ability to improve engagement between state policymakers’
and the prevention science community, build policymakers’ awareness and value of substance misuse
prevention research, and subsequently their use of research evidence throughout the policymaking process. To
accomplish this, we will test three specific research aims. Aim 1 will assess historical and current use of research
evidence in state legislation pertaining to substance misuse prevention. This will involve qualitative coding of
bills introduced by state legislatures over the last five years. Aim 2 will compare the frequency and quality of
engagement with prevention researchers between the intervention and control conditions. Additionally, we will
assess how the RPC model influences policymakers’ value and awareness of substance misuse prevention over
time using a validated survey across three time points. Aim 3 will evaluate the effectiveness of the RPC on
legislators’ actual use of research in legislation by observing and quantifying changes in legislator behavior
related to research use. Improving the use of scientific information in policymaking can reduce population-level
substance misuse by increasing the availability of evidence-based prevention programs and policies.
项目摘要
如果科学要为政策提供信息并最终改善公共卫生,该领域需要一个有效的战略,
支持决策者使用研究证据。然而,我们的领域缺乏一个基于证据的模型,
支持国家政策制定者在制定立法时使用预防研究。相反,我们继续
在很大程度上依赖于将预防研究转化为行动的临时战略(例如,机会性外联和应对
政策制定者的要求,如果或当他们提出)。因此,我们提出了一个正式的实验研究,
以理论为基础的方法,支持决策者使用不涉及游说的科学证据-
研究与政策协作(RPC)模式。RPC促进了政策与
通过实施系统的能力建设和外联战略,加强与研究界的合作。先前
RPC的实验工作证明了这种模式能够增加
研究人员和政策制定者,增加政策制定者对研究证据的价值,并改善他们对
1我们提出了一个州一级的RPC随机对照试验(N =
30个州立法机构),将评估该模型改善州政策制定者之间接触的能力。
和预防科学界,建立决策者对药物滥用的认识和价值观
预防研究,以及随后在整个决策过程中使用研究证据。到
为此,我们将测试三个具体的研究目标。目标1将评估研究的历史和当前使用情况
国家立法中有关预防药物滥用的证据。这将涉及定性编码,
在过去的五年里,州立法机构提出的法案。目标2将比较
在干预和控制条件之间与预防研究人员接触。此外,我们将
评估RPC模型如何影响决策者的价值观和对药物滥用预防的认识,
时间使用经过验证的调查在三个时间点。目标3将评估RPC的有效性,
立法者通过观察和量化立法者行为的变化,在立法中实际使用研究
与研究用途有关。在决策中更好地利用科学信息可以减少人口
通过增加基于证据的预防方案和政策的可用性来减少药物滥用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Max Crowley其他文献
Daniel Max Crowley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Max Crowley', 18)}}的其他基金
Investing in Prevention Infrastructure: Economic Evaluation of the PROSPER System
投资预防基础设施:PROSPER 系统的经济评估
- 批准号:
10639353 - 财政年份:2023
- 资助金额:
$ 76.05万 - 项目类别:
Strengthening Benefit-Cost Analyses of Substance Abuse Prevention
加强预防药物滥用的效益成本分析
- 批准号:
8397364 - 财政年份:2012
- 资助金额:
$ 76.05万 - 项目类别:
Strengthening Benefit-Cost Analyses of Substance Abuse Prevention
加强预防药物滥用的效益成本分析
- 批准号:
8537748 - 财政年份:2012
- 资助金额:
$ 76.05万 - 项目类别:
Strengthening Benefit-Cost Analyses of Substance Abuse Prevention
加强预防药物滥用的效益成本分析
- 批准号:
8720742 - 财政年份:2012
- 资助金额:
$ 76.05万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 76.05万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 76.05万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 76.05万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 76.05万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 76.05万 - 项目类别:
Standard Grant